Stock Scorecard



Stock Summary for Incyte Corp (INCY) - $60.81 as of 5/13/2025 8:41:16 PM EST

Total Score

11 out of 30

Safety Score

50 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for INCY

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for INCY

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for INCY

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for INCY

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for INCY (50 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 6
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 1
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for INCY

Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update - Merus ( NASDAQ:MRUS ) 5/7/2025 8:11:00 PM
Annual NMDP ( SM ) Gala in New York City Raises Over a Half Million Dollars, Enabling More Patients to Receive Life-Saving Cell Therapy 5/6/2025 6:06:00 PM
INCY Q1 Earnings & Revenues Beat Estimates on Higher Product Sales 4/29/2025 3:04:00 PM
Incyte ( INCY ) Q1 Earnings and Revenues Top Estimates 4/29/2025 12:15:00 PM
Biomed Valley Discoveries Announces First Patient Dosed in Phase 1/2 Combination Study of Ulixertinib with Ruxolitinib ( Jakafi® ) in Patients with Myelofibrosis 4/28/2025 11:00:00 AM
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises 4/25/2025 12:50:00 PM
Blueprint Medicines ( BPMC ) Expected to Beat Earnings Estimates: Should You Buy? 4/24/2025 2:01:00 PM
Incyte Gears Up to Report Q1 Earnings: Here's What You Should Know 4/23/2025 11:50:00 AM
Incyte ( INCY ) Reports Next Week: Wall Street Expects Earnings Growth 4/22/2025 2:01:00 PM
Joshua Grass, John Kelly, and Lauren Daniel Join 5AM Ventures 4/21/2025 12:00:00 PM

Financial Details for INCY

Company Overview

Ticker INCY
Company Name Incyte Corp
Country USA
Description Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.
Sector Name TRADE & SERVICES
Industry Name SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Most Recent Quarter 3/31/2025
Next Earnings Date 7/28/2025

Stock Price History

Last Day Price 60.81
Price 4 Years Ago 73.40
Last Day Price Updated 5/13/2025 8:41:16 PM EST
Last Day Volume 1,548,637
Average Daily Volume 2,117,843
52-Week High 83.95
52-Week Low 53.56
Last Price to 52 Week Low 13.54%

Valuation Measures

Trailing PE 294.90
Industry PE 64.66
Sector PE 47.93
5-Year Average PE 35.59
Free Cash Flow Ratio 6.06
Industry Free Cash Flow Ratio 39.42
Sector Free Cash Flow Ratio 75.97
Current Ratio Most Recent Quarter 2.04
Total Cash Per Share 10.03
Book Value Per Share Most Recent Quarter 18.93
Price to Book Ratio 3.11
Industry Price to Book Ratio 6.27
Sector Price to Book Ratio 10.52
Price to Sales Ratio Twelve Trailing Months 2.59
Industry Price to Sales Ratio Twelve Trailing Months 2.75
Sector Price to Sales Ratio Twelve Trailing Months 2.11
Analyst Buy Ratings 8
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 193,570,000
Market Capitalization 11,770,991,700
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.59%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 6.70%
Annual Earnings Growth -94.54%
Reported EPS 12 Trailing Months 0.20
Reported EPS Past Year 1.16
Reported EPS Prior Year 1.32
Net Income Twelve Trailing Months 21,270,000
Net Income Past Year 32,615,000
Net Income Prior Year 597,599,000
Quarterly Revenue Growth YOY 19.50%
5-Year Revenue Growth 14.46%
Operating Margin Twelve Trailing Months 20.60%

Balance Sheet

Total Cash Most Recent Quarter 1,941,722,000
Total Cash Past Year 1,687,829,000
Total Cash Prior Year 3,213,376,000
Net Cash Position Most Recent Quarter 1,908,180,000
Net Cash Position Past Year 1,654,287,000
Long Term Debt Past Year 33,542,000
Long Term Debt Prior Year 29,162,000
Total Debt Most Recent Quarter 33,542,000
Equity to Debt Ratio Past Year 0.99
Equity to Debt Ratio Most Recent Quarter 0.99
Total Stockholder Equity Past Year 3,447,628,000
Total Stockholder Equity Prior Year 5,189,837,000
Total Stockholder Equity Most Recent Quarter 3,667,563,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 288,810,000
Free Cash Flow Per Share Twelve Trailing Months 1.49
Free Cash Flow Past Year 249,074,000
Free Cash Flow Prior Year 449,001,000

Options

Put/Call Ratio 2.43
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.25
MACD Signal -0.49
20-Day Bollinger Lower Band 54.24
20-Day Bollinger Middle Band 66.37
20-Day Bollinger Upper Band 78.50
Beta 0.68
RSI 48.18
50-Day SMA 66.32
150-Day SMA 66.63
200-Day SMA 68.17

System

Modified 5/13/2025 2:42:54 AM EST